Zenarestat
|
|
Zenarestat Eigenschaften
- Schmelzpunkt:
- 223-224°
- Siedepunkt:
- 624.4±65.0 °C(Predicted)
- Dichte
- 1.737
- L?slichkeit
- DMSO : 100 mg/mL (226.43 mM; Need ultrasonic)
- pka
- 3.76±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to off-white
Sicherheit
Zenarestat Chemische Eigenschaften,Einsatz,Produktion Methoden
Originator
FK 366 ,Fujisawa PharmaceuticalVerwenden
Treatment of diabetic neuropathy (aldose reductase inhibitor).Therapeutic Function
Aldose reductase inhibitorZenarestat Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Natriumhydroxid
Essigsure
Hydrogenchlorid
Ethyl-bromacetat
N,N-Diethylethanamin
4-chloro-2-nitrobenzoyl chloride
4-BROMO-2-FLUOROBENZYLAMINE
Natriumhydrid
Downstream Produkte
Zenarestat Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 13)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Hubei Jusheng Technology Co.,Ltd. | 18871490254 |
linda@hubeijusheng.com | CHINA | 28172 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49733 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49734 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354; |
support@targetmol.com | United States | 38838 | 58 |
TargetMol Chemicals Inc. | +17819995354 |
marketing@targetmol.com | United States | 19939 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 |
customer_service@efebio.com | China | 11973 | 58 |
TargetMol Chemicals Inc. | 15002134094 |
marketing@targetmol.cn | China | 26070 | 58 |
Merck KGaA | 21-20338288 |
ordercn@merckgroup.com | China | 6394 | 58 |
- 3-(2-Fluoro-4-bromobenzyl)-7-chloro-2,4(1H,3H)-dioxoquinazoline-1-acetic acid
- 3-[(4-Bromo-2-fluorophenyl)methyl]-7-chloro-3,4-dihydro-2,4-dioxo-1(2H)-quinazolineacetic acid
- FK-366
- Zenarestat
- FR 74366
- 2-[3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-2,4-dioxoquinazolin-1-yl]acetic acid
- [3-(4-Bromo-2-fluorobenzyl)-7-chloro-2,4-dioxo-3,4-dihydro-1(2H)- quinazolinyl]acetic acid
- 1(2H)-Quinazolineacetic acid, 3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-3,4-dihydro-2,4-dioxo-
- CI1014
- CI-1014
- 112733-06-9
- C17H11BrClFN2O4